I promise

"I promise, Suzy... Even if it takes the rest of my life." - Nancy G. Brinker, founder of Susan G. Komen for the Cure

What is Triple Negative Breast Cancer?

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" type of cancer. Being Triple Negative, you don't have a targeted therapy and that your only treatment option is chemotherapy.

Triple Negative is seen in about 15% of all breast cancers. Triple Negative is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TN is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Carpe diem

Seize Each new Day with Renewed Strength,
Believe in Yourself, Go forward with
Courage and faith
to face whatever Tomorrow may bring.

Chicks For Charity motto:

Enjoy life. Laugh a lot.
Work hard. Play hard.
Be thankful for our blessings.
Share the wisdom. Give back
.

Saturday, March 2, 2013

This is the Bill, Our Bill: H.R. 80: Triple-Negative Breast Cancer Research and Education Act of 2013


HR 80 IH
113th CONGRESS
1st Session
H. R. 80
To provide for research and education with respect to triple-negative breast cancer, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES

January 3, 2013

Ms. JACKSON LEE introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL
To provide for research and education with respect to triple-negative breast cancer, and for other purposes.
    Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ‘Triple-Negative Breast Cancer Research and Education Act of 2013’.

SEC. 2. FINDINGS.

    Congress finds as follows:
      (1) Breast cancer accounts for 1 in 4 cancer diagnoses among women in this country.
      (2) The survival rate for breast cancer has increased to 90 percent for White women and 78 percent for African-American women.
      (3) African-American women are more likely to be diagnosed with larger tumors and more advanced stages of breast cancer despite a lower incidence rate.
      (4) Early detection for breast cancer increases survival rates for breast cancer, as evidenced by a 5-year relative survival rate of 98 percent for breast cancers that are discovered before the cancer spreads beyond the breast, compared to 23 percent for stage IV breast cancers.
      (5) Triple-negative breast cancer is a term used to describe breast cancers whose cells do not have estrogen receptors and progesterone receptors, and do not have an excess of the HER2 protein on their sources.
      (6) It is estimated that between 10 and 20 percent of female breast cancer patients are diagnosed with triple-negative breast cancer, and studies indicate the prevalence of triple-negative breast cancer is much higher.
      (7) Triple-negative breast cancer most commonly affects African-American women, followed by Hispanic women.
      (8) Triple-negative breast cancer is a very aggressive form of cancer which affects women under the age of 50 across all racial and socioeconomic backgrounds.
      (9) African-American women are 3 times more likely to develop triple-negative breast cancer than White women.
      (10) Triple-negative breast cancer tends to grow and spread more quickly than most other types of breast cancer.
      (11) Like other forms of breast cancer, triple-negative breast cancer is treated with surgery, radiation therapy, or chemotherapy.
      (12) Early-stage detection of triple-negative breast cancer is the key to survival because the tumor cells lack certain receptors, and neither hormone therapy nor drugs that target these receptors are effective against these cancers; therefore, early detection and education is vital.
      (13) Current research and available data do not provide adequate information on--
        (A) the rates of prevalence and incidence of triple-negative breast cancer in African-American, Hispanic, and other minority women;
        (B) he costs associated with treating triple-negative breast cancer; and
        (C) the methods by which triple-negative breast cancer may be prevented or cured in these women.

SEC. 3. RESEARCH WITH RESPECT TO TRIPLE-NEGATIVE BREAST CANCER.

    (a) Research- The Director of the National Institutes of Health (in this section referred to as the ‘Director of NIH’) shall expand, intensify, and coordinate programs for the conduct and support of research with respect to triple-negative breast cancer.
    (b) Administration- The Director of NIH shall carry out this section through the appropriate institutes, offices, and centers of the National Institutes of Health, including the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Environmental Health Sciences, the Office of Research on Women’s Health, and the National Institute on Minority Health and Health Disparities.
    (c) Coordination of Activities- The Director of the Office of Research on Women’s Health shall coordinate activities under this section among the institutes, offices, and centers of the National Institutes of Health.
    (d) Authorization of Appropriations- For the purpose of carrying out this section, there are authorized to be appropriated $500,000 for each of the fiscal years 2014 through 2016.

SEC. 4. EDUCATION AND DISSEMINATION OF INFORMATION WITH RESPECT TO TRIPLE-NEGATIVE BREAST CANCER.

    (a) Triple-Negative Breast Cancer Public Education Program- The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, shall develop and disseminate to the public information regarding triple-negative breast cancer, including information on--
      (1) the incidence and prevalence of triple-negative breast cancer among women;
      (2) the elevated risk for minority women to develop triple-negative breast cancer; and
      (3) the availability, as medically appropriate, of a range of treatment options for symptomatic triple-negative breast cancer.
    (b) Dissemination of Information- The Secretary may disseminate information under subsection (a) directly or through arrangements with nonprofit organizations, consumer groups, institutions of higher education, Federal, State, or local agencies, or the media.
    (c) Authorization of Appropriations- For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2014 through 2016.

SEC. 5. INFORMATION TO HEALTH CARE PROVIDERS WITH RESPECT TO TRIPLE-NEGATIVE BREAST CANCER.

    (a) Dissemination of Information- The Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, shall develop and disseminate to health care providers information on triple-negative breast cancer for the purpose of ensuring that health care providers remain informed about current information on triple-negative breast cancer. Such information shall include the elevated risk for minority women to develop triple-negative breast cancer and the range of available options for the treatment of symptomatic triple-negative breast cancer.
    (b) Authorization of Appropriations- For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2014 through 2018.

SEC. 6. DEFINITION.

    In this Act, the term ‘minority women’ means women who are members of a racial and ethnic minority group, as defined in section 1707(g) of the Public Health Service Act (42 U.S.C. 300u-6(g)).

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Total Pageviews

Click to help fund mammograms for the uninsured

The Breast Cancer Site

Click to join me in support group

Inspire health and wellness support groups

Triple Negative Breast Cancer Foundation

Triple Negative Breast Cancer Foundation
"click image to link"

"Click image to link"

The SCAR Project

The SCAR Project
"Click image to link"

CRABBYCARDS.COM

CRABBYCARDS.COM
"Click image to link"

Breast Cancer Awareness Body Painting Project

Breast Cancer Awareness Body Painting Project
"Click image to link"